Related Experiment Video
Updated: Jun 29, 2025

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
Flexible scaffold-based cheminformatics approach for polypharmacological drug design
Zhangcheng Chen1, Jing Yu1, Huan Wang2
1Key Laboratory of Multi-Cell Systems, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai 200031, China.
Designing polypharmacological drugs for central nervous system (CNS) disorders is challenging. A new flexible scaffold-based cheminformatics approach (FSCA) enables rational drug design by utilizing specific binding poses for multi-target engagement.
Area of Science:
- Medicinal Chemistry
- Neuroscience
- Computational Chemistry
Background:
- Treatments for complex central nervous system (CNS) disorders necessitate drugs with polypharmacology and multifunctionality.
- Designing multi-target drugs remains a significant challenge in medicinal chemistry.
Purpose of the Study:
- To present a novel flexible scaffold-based cheminformatics approach (FSCA) for the rational design of polypharmacological drugs.
- To demonstrate the application of FSCA using a novel compound targeting 5-HT2A and 5-HT1A receptors.
Main Methods:
- FSCA involves fitting a flexible scaffold to different receptors using distinct binding poses.
- Analysis of aminergic receptor structures identified key motifs: 'agonist filter' and 'conformation shaper'.
- The compound IHCH-7179 was designed using FSCA, adopting different binding poses at 5-HT2A and 5-HT1A receptors.
Main Results:
- IHCH-7179 acted as an antagonist at 5-HT2A receptors and an agonist at 5-HT1A receptors.
- IHCH-7179 demonstrated efficacy in alleviating cognitive deficits and psychoactive symptoms in mouse models.
- The identified motifs predict ligand binding pose and activity at aminergic receptors.
Conclusions:
- FSCA provides a rational strategy for designing polypharmacological drugs.
- The identified motifs are crucial for predicting ligand behavior at aminergic receptors.
- FSCA can be extended to design polypharmacological ligands for other receptor targets.
Related Concept Videos
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Drug Discovery: Overview
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Model Approaches for Pharmacokinetic Data: Compartment Models
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Analysis of Population Pharmacokinetic Data

